Atrial fibrillation at mid-term after bioprosthetic aortic valve replacement – implications for anti-thrombotic therapy.

@article{Tosello2015AtrialFA,
  title={Atrial fibrillation at mid-term after bioprosthetic aortic valve replacement – implications for anti-thrombotic therapy.},
  author={F. Tosello and E. Florens and Thibault Caruba and C. Lebeller and L. Mimoun and A. Milan and J. Fabiani and P. Boutouyrie and P. Menasch{\'e} and A. Lillo-Lelouet},
  journal={Circulation journal : official journal of the Japanese Circulation Society},
  year={2015},
  volume={79 1},
  pages={
          70-6
        }
}
BACKGROUND Little is known about mid-term (3-month) postoperative atrial fibrillation (MT-POAF) in patients treated with bioprosthetic aortic valve replacement (BAVR). The aim of this study was to describe the natural history, identify the predictors and investigate the potential consequences in terms of anti-thrombotic therapy. METHODS AND RESULTS During a longitudinal, prospective study, 219 patients were treated with BAVR early (7 days) and at mid-term postoperatively (30 and 90 days… Expand
Long-term outcomes of catheter ablation of atrial fibrillation post-cardiac valve replacement.
The impact of volume substitution on post‐operative atrial fibrillation

References

SHOWING 1-10 OF 55 REFERENCES
Impact of concomitant surgical atrial fibrillation ablation in patients undergoing aortic valve replacement.
  • J. Yoo, J. Kim, +5 authors C. Chung
  • Medicine
  • Circulation journal : official journal of the Japanese Circulation Society
  • 2014
Long-term outcome of the carpentier-edwards pericardial valve in the aortic position in Japanese patients.
Atrial fibrillation following open heart surgery: long-term incidence and prognosis
Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality.
Body mass index predicts new-onset atrial fibrillation after cardiac surgery.
...
1
2
3
4
5
...